OA-29 Mezigdomide (MEZI), Tazemetostat (TAZ), and Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the CA057-003 Trial

Luciano Costa,Rakesh Popat, David Siegel,Fredrik Schjesvold,Saad Usmani,Nizar J. Bahlis,Albert Oriol,Michael Chu, Syed Abbas Ali, Karthik Ramasamy,Monique Hartley-Brown, Joaquín Martínez-Lopez, Allison Gaudy, Antonina Kurtova, Wen Zhang,Rafael Sarmiento, August Dietrich,Jessica Katz,Michael Pourdehnad,Paul Richardson

Clinical Lymphoma Myeloma and Leukemia（2024）

引用 0|浏览0

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要